_version_ 1785090454175350784
author Dodero, Anna
Guidetti, Anna
Chiappella, Annalisa
Ljevar, Silva
Pennisi, Martina
Zinzani, Pier Luigi
Casadei, Beatrice
Bramanti, Stefania
Santoro, Armando
Chiusolo, Patrizia
Rocco, Alice DI
Palma, Martina DI
Tisi, Maria Chiara
Cutini, Ilaria
Carrabba, Matteo
Musso, Maurizio
Martino, Massimo
Barbui, Anna Maria
Novo, Mattia
Grillo, Giovanni
Battista, Martalisa
Zanni, Manuela
Arcaini, Luca
Miceli, Rosalba
Magni, Martina
Carniti, Cristiana
Corradini, Paolo
author_facet Dodero, Anna
Guidetti, Anna
Chiappella, Annalisa
Ljevar, Silva
Pennisi, Martina
Zinzani, Pier Luigi
Casadei, Beatrice
Bramanti, Stefania
Santoro, Armando
Chiusolo, Patrizia
Rocco, Alice DI
Palma, Martina DI
Tisi, Maria Chiara
Cutini, Ilaria
Carrabba, Matteo
Musso, Maurizio
Martino, Massimo
Barbui, Anna Maria
Novo, Mattia
Grillo, Giovanni
Battista, Martalisa
Zanni, Manuela
Arcaini, Luca
Miceli, Rosalba
Magni, Martina
Carniti, Cristiana
Corradini, Paolo
author_sort Dodero, Anna
collection PubMed
description
format Online
Article
Text
id pubmed-10428376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283762023-08-17 S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE). Dodero, Anna Guidetti, Anna Chiappella, Annalisa Ljevar, Silva Pennisi, Martina Zinzani, Pier Luigi Casadei, Beatrice Bramanti, Stefania Santoro, Armando Chiusolo, Patrizia Rocco, Alice DI Palma, Martina DI Tisi, Maria Chiara Cutini, Ilaria Carrabba, Matteo Musso, Maurizio Martino, Massimo Barbui, Anna Maria Novo, Mattia Grillo, Giovanni Battista, Martalisa Zanni, Manuela Arcaini, Luca Miceli, Rosalba Magni, Martina Carniti, Cristiana Corradini, Paolo Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428376/ http://dx.doi.org/10.1097/01.HS9.0000967824.45449.d2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Dodero, Anna
Guidetti, Anna
Chiappella, Annalisa
Ljevar, Silva
Pennisi, Martina
Zinzani, Pier Luigi
Casadei, Beatrice
Bramanti, Stefania
Santoro, Armando
Chiusolo, Patrizia
Rocco, Alice DI
Palma, Martina DI
Tisi, Maria Chiara
Cutini, Ilaria
Carrabba, Matteo
Musso, Maurizio
Martino, Massimo
Barbui, Anna Maria
Novo, Mattia
Grillo, Giovanni
Battista, Martalisa
Zanni, Manuela
Arcaini, Luca
Miceli, Rosalba
Magni, Martina
Carniti, Cristiana
Corradini, Paolo
S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title_full S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title_fullStr S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title_full_unstemmed S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title_short S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
title_sort s228: positron emission tomography evaluation in a large group of patients affected by relapsed/refractory b-cell lymphomas treated with anti-19 chimeric antigen receptor (car) t-cells therapy (cart sie).
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428376/
http://dx.doi.org/10.1097/01.HS9.0000967824.45449.d2
work_keys_str_mv AT doderoanna s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT guidettianna s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT chiappellaannalisa s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT ljevarsilva s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT pennisimartina s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT zinzanipierluigi s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT casadeibeatrice s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT bramantistefania s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT santoroarmando s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT chiusolopatrizia s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT roccoalicedi s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT palmamartinadi s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT tisimariachiara s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT cutiniilaria s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT carrabbamatteo s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT mussomaurizio s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT martinomassimo s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT barbuiannamaria s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT novomattia s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT grillogiovanni s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT battistamartalisa s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT zannimanuela s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT arcainiluca s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT micelirosalba s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT magnimartina s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT carniticristiana s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie
AT corradinipaolo s228positronemissiontomographyevaluationinalargegroupofpatientsaffectedbyrelapsedrefractorybcelllymphomastreatedwithanti19chimericantigenreceptorcartcellstherapycartsie